Amarin Corp PLC (AMRN) stock
AMRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 10/3061% above fair value
$11.27−0.04 (-0.35%)
Close on Nov 17, 2026Market cap $249.12MP/E –Yield –
Amarin total assets
Total assets on the balance sheet at the end of each period.
Amarin's total assets was $634.08M at Sep 30, 2026. For fiscal 2025 it was $670.78M, down 2.1% from the year before. Over ten years it grew 14.5% a year on average. The highest annual figure on record is $1.07B in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $670.78M | -2.1% |
| FY2024 | Dec 31, 2024 | $685.35M | -17.6% |
| FY2023 | Dec 31, 2023 | $831.68M | -6.1% |
| FY2022 | Dec 31, 2022 | $886.18M | -17.0% |
| FY2021 | Dec 31, 2021 | $1.07B | +10.6% |
| FY2020 | Dec 31, 2020 | $966.02M | +9.5% |
| FY2019 | Dec 31, 2019 | $882.21M | +128.7% |
| FY2018 | Dec 31, 2018 | $385.71M | +138.7% |
| FY2017 | Dec 31, 2017 | $161.60M | -3.2% |
| FY2016 | Dec 31, 2016 | $167.00M | -3.6% |
| FY2015 | Dec 31, 2015 | $173.23M | +1.2% |
| FY2014 | Dec 31, 2014 | $171.11M | -32.2% |
| FY2013 | Dec 31, 2013 | $252.48M | -18.8% |
| FY2012 | Dec 31, 2012 | $310.86M | +146.0% |
| FY2011 | Dec 31, 2011 | $126.38M | +257.3% |
| FY2010 | Dec 31, 2010 | $35.37M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $634.08M | -3.9% |
| Q2 FY2026 | Jun 30, 2026 | $624.36M | -6.8% |
| Q1 FY2026 | Mar 31, 2026 | $645.76M | -1.5% |
| Q4 FY2025 | Dec 31, 2025 | $670.78M | -2.1% |
| Q3 FY2025 | Sep 30, 2025 | $659.81M | -12.1% |
| Q2 FY2025 | Jun 30, 2025 | $670.13M | -16.2% |
| Q1 FY2025 | Mar 31, 2025 | $655.68M | -17.0% |
| Q4 FY2024 | Dec 31, 2024 | $685.35M | -17.6% |
| Q3 FY2024 | Sep 30, 2024 | $750.62M | -10.5% |
| Q2 FY2024 | Jun 30, 2024 | $799.86M | -7.0% |
| Q1 FY2024 | Mar 31, 2024 | $790.01M | -8.2% |
| Q4 FY2023 | Dec 31, 2023 | $831.68M | -6.1% |
| Q3 FY2023 | Sep 30, 2023 | $839.03M | -7.6% |
| Q2 FY2023 | Jun 30, 2023 | $860.02M | -11.6% |
| Q1 FY2023 | Mar 31, 2023 | $860.19M | -11.7% |
| Q4 FY2022 | Dec 31, 2022 | $886.18M | -17.0% |
| Q3 FY2022 | Sep 30, 2022 | $908.30M | -12.3% |
| Q2 FY2022 | Jun 30, 2022 | $973.24M | -6.9% |
| Q1 FY2022 | Mar 31, 2022 | $973.71M | -1.7% |
| Q4 FY2021 | Dec 31, 2021 | $1.07B | +10.6% |
| Q3 FY2021 | Sep 30, 2021 | $1.04B | +7.9% |
| Q2 FY2021 | Jun 30, 2021 | $1.04B | +14.2% |
| Q1 FY2021 | Mar 31, 2021 | $990.25M | +7.0% |
| Q4 FY2020 | Dec 31, 2020 | $966.02M | +9.5% |
| Q3 FY2020 | Sep 30, 2020 | $960.20M | +10.8% |
| Q2 FY2020 | Jun 30, 2020 | $914.87M | +134.6% |
| Q1 FY2020 | Mar 31, 2020 | $925.67M | +148.7% |
| Q4 FY2019 | Dec 31, 2019 | $882.21M | +128.7% |
| Q3 FY2019 | Sep 30, 2019 | $866.94M | +312.3% |
| Q2 FY2019 | Jun 30, 2019 | $389.92M | +91.0% |
| Q1 FY2019 | Mar 31, 2019 | $372.24M | +72.6% |
| Q4 FY2018 | Dec 31, 2018 | $385.71M | +138.7% |
| Q3 FY2018 | Sep 30, 2018 | $210.29M | +26.2% |
| Q2 FY2018 | Jun 30, 2018 | $204.13M | +19.9% |
| Q1 FY2018 | Mar 31, 2018 | $215.71M | +23.1% |
| Q4 FY2017 | Dec 31, 2017 | $161.60M | -3.2% |
| Q3 FY2017 | Sep 30, 2017 | $166.61M | – |
| Q2 FY2017 | Jun 30, 2017 | $170.19M | – |
| Q1 FY2017 | Mar 31, 2017 | $175.20M | – |
| Q4 FY2016 | Dec 31, 2016 | $167.00M | – |
See a number that looks wrong?